
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
FineHeart is a clinical stage medical device company based in Bordeaux, France. Its innovative product, FLOWMAKER, has the potential to treat 200,000 patients with advanced heart failure each year. FineHeart will initially target the 50,000 most severe patients who are eligible for cardiac assistance. Initial estimates value this market segment to be worth over US$5 billion. FineHeart was founded by CEO Arnaud Mascarell and a team of internationally renowned cardiac surgeons and electro-physiologists, including Dr. Stephane Garrigue, CSO and inventor of the concept, and Dr. Philippe Ritter, co-inventor of cardiac resynchronization therapy (CRT). The company holds an international portfolio of...
Cardiac assistance,implantable cardiac output management system,medical device,mechatronic medicine,and heart failure
Fineheart operates in the Medical equipment manufacturing industry.
Fineheart's revenue is 11m - 100m
Fineheart has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.